Personalis to Participate at Upcoming Investor Conferences
2023年8月2日 - 5:01AM
ビジネスワイヤ(英語)
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for precision oncology, announced today that its management team
will participate at the following investor conferences:
- 8th Annual Needham Virtual MedTech & Diagnostics 1x1
Conference Participating on Monday, August 14, 2023
- Sidoti Virtual Micro Cap Conference Presenting on Wednesday,
August 16, 2023 at 12:15 p.m. Eastern Time
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest timepoints, enable selection of targeted
therapies based on ultra-comprehensive genomic profiling, and
enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230801461002/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Personalis (NASDAQ:PSNL)
過去 株価チャート
から 4 2024 まで 5 2024
Personalis (NASDAQ:PSNL)
過去 株価チャート
から 5 2023 まで 5 2024